Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds
November 22, 2017Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma
A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …
‘Brain training’ found to reduce risk of dementia by 29%
November 22, 2017Research and Development biotech, dementia, drugs, pharma, pharmaceutical
In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
FDA approves first-ever two-drug HIV regimen, GSK’s Juluca
November 22, 2017Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma
GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
EU approves opioid treatment, amid fears of US-like crisis
November 22, 2017Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical
The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
Making careers in medcomms more visible – Synergy Vision launches new recruitment website
November 22, 2017Medical Communications Synergy Vision, csr, graduate recruitment, medical communcations, recruitment
“I’d never heard of med comms until I wanted to change career and started exploring my options” – it’s a …
Free Webinar: The End Game – Payer Engagement
November 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical
In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
Boehringer offers its molecules to the scientific community via new platform
November 21, 2017Manufacturing and Production, Research and Development Boehringer Ingelheim, pharma
Boehringer Ingelheim has unveiled opnME.com, a centralised platform which makes available selected pre-clinical molecules from its portfolio for free, accessible …
Obesity leads to larger, harder-to-detect tumours in breast cancer, study finds
November 21, 2017Manufacturing and Production, Research and Development Cancer, breast cancer, pharma
A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …
NHS faced with 5,700% increase in drug price, finds CMA
November 21, 2017Manufacturing and Production, Medical Communications CMA, Concordia, biotech, drugs, pharma, pharmaceutical
The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …
And the winner is…Amsterdam takes EMA HQ
November 21, 2017Manufacturing and Production, Medical Communications biotech, drugs, pharma, pharmaceutical
In a decision that was likened to a penalty shoot-out, Amsterdam was announced as the winner of the race to …
Partnerships hold the key to making HIV history
November 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Janssen, pharma
Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be …
Acorda scraps Parkinson’s drug after five trial deaths
November 20, 2017Research and Development, Sales and Marketing Acorda therapeutics, Parkinson's, patient deaths, pharma
Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …
Children are still prescribed codeine despite FDA warnings, study finds
November 20, 2017Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma
A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …
Roche unveils strong combination treatment data in lung cancer
November 20, 2017Research and Development, Sales and Marketing Cancer, NSCLC< lung cancer, Roche, avastin, immunotherapy, pharma, tecentriq
Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …
Novartis’s Tasigna scores EU approval in paediatric patients
November 20, 2017Sales and Marketing Europe, Novartis, Tasigna, chronic myeloid leukaemia, pharma
Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in …
Samsung Bioepis’ Ontruzant becomes first Herceptin biosimilar approved in Europe
November 20, 2017Sales and Marketing EMA, Herceptin, Roche, Samsung Bioepis
Samsung Bioepis has announced that Ontruzant, the company’s biosimilar version of Roche’s Herceptin, has been awarded marketing authorisation in Europe …
UK austerity measures to social care led to 120,000 deaths
November 17, 2017Medical Communications UK, austerity, biotech, drugs, pharma, pharmaceutical, social care
A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …
Top Ten most popular articles on Pharmafile.com this week
November 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile, top ten
It’s Friday, and it’s time for another rundown of our most popular articles with our readers this week. Besides a …
FDA expands use of Pfizer’s Sutent in kidney cancer
November 17, 2017Medical Communications, Sales and Marketing Cancer, Kidney cancer, Pfizer, Sutent, pharma
Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …
Roche’s haemophillia A treatment gets nod but with black box warning
November 17, 2017Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
